BioSpace News Archive

Carmot Therapeutics, Inc. today announced that it has appointed Charles “Charlie” Newton to its Board of Directors.

Inozyme Pharma, Inc. today announced that it will host a conference call to provide an update on the Company’s ENPP1 Deficiency program on July 26, 2023, at 8am ET.

Beckman Coulter, a global leader in clinical diagnostics, today announced it will debut its hematology analyzer and slidemaker stainer connected to Scopio Labs’ digital morphology platform for end-to-end digitization with artificial intelligence-assisted peripheral blood smear analysis at the 2023 American Association for Clinical Chemistry (AACC) Annual Scientific Meeting and Clinical Lab Expo.

Schrödinger will report its second quarter 2023 financial results on Wednesday, August 2, 2023, after the financial markets close.

Visiox Pharma, Inc. today announced it has entered into a definitive agreement with Santen Pharmaceutical Co., Ltd to license OMLONTI ®.

Welltower® Inc. (NYSE: WELL) today announced it will release second quarter 2023 financial results after the close of trading on the New York Stock Exchange on Monday, July 31, 2023.

Nicox SA provided financial and business highlights for the second quarter 2023 for Nicox SA and its subsidiaries.

Diadem SpA announced that study data being presented at the Alzheimer’s Association International Conference® 2023 further strengthens the evidence supporting the prognostic value of Diadem’s AlzoSure® Predict blood-based biomarker test, which can accurately identify whether or not individuals over the age of 50 will experience a significant cognitive decline due to AD years before the full onset of symptoms.

MindBio Therapeutics Corp. is pleased to have started pre-screening for participant entry into Phase 2 LSD-Microdosing clinical trials.

Telix Pharmaceuticals Limited issues its Appendix 4C quarterly cash flow report and accompanying Activities Report for the quarter ended 30 June 2023.